SOPH Q4 2024 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena

SOPHSOPHiA GENETICS S.A.

$308M

Q4 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$18M+4.0% YoY

Gross Profit

$12M68.2% margin

Operating Income

-$17M-98.4% margin

Net Income

-$15M-85.5% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+11.9%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$13M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$155M

Total Liabilities

$59M

Stockholders' Equity

$96M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$17M	+4.0%
Gross Profit	$12M	$12M	+1.7%
Operating Income	-$17M	-$19M	+7.9%
Net Income	-$15M	-$24M	+37.0%